Trial Profile
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 for the Development of Org 36286 (Corifollitropin Alfa)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2022
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary) ; Recombinant follicle-stimulating hormone
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms COMPLETED
- Sponsors Merck Sharp & Dohme; Organon; Schering-Plough
- 07 Oct 2009 Schering-Plough added as trial sponsor, affiliate and lead trial center as reported by ClinicalTrials.gov.
- 16 Jul 2008 New trial record.